N/A
N=748
TYRO Champion Dads Project Study
Fathers
Bottom Line
View on ClinicalTrials.gov: NCT05256992 ↗Enrolled (actual)
748
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Primary Outcome Measures 1: Healthy Parenting Behavior — 3.88; 3.67 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Standard Servies + Ray of Hope Curriculum (Other); Standard Services (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Midwest Evaluation & Research
- Primary completion
- May 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Primary Outcome Measures 1: Healthy Parenting Behavior |
3.88; 3.67 | — |
| PRIMARY Primary Outcome Measures 2: Healthy Parenting Behavior |
4.5; 4.74 | — |
| PRIMARY Primary Outcome Measure 3: Healthy Co-parenting Behavior |
3.51; 3.50 | — |
| PRIMARY Primary Outcome Measures 4: Healthy Partner Relationship Behavior |
3.94; 3.97 | — |
| SECONDARY Secondary Outcome Measure 1: Healthy Parenting Attitudes |
4.72; 4.76 | — |
Summary
This impact evaluation aims to determine if the addition of 10 hours of domestic violence prevention programming is effective at improving outcomes among those program participants who are randomly assigned to the treatment group. Both study groups will receive standard TYRO Champion Dads services (the TYRO Dads and TYRO Core Communication evidence-based curricula, plus support services), but only the treatment group will be offered the additional Ray of Hope curriculum hours focused on mitigating risk factors related to domestic violence.
Eligibility Criteria
Inclusion Criteria
- Adult (age 18 and older)
- Father (children must be no more than 24 years of age)
- must have no open criminal cases (can be deferred)
Exclusion Criteria
- Minor (under the age of 18)
- Not a father
- Has an open criminal case
Data sourced from ClinicalTrials.gov (NCT05256992). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.